One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment

A A M van der Veldt; S F Oosting; R S N Fehrmann; C H GeurtsvanKessel; R S van Binnendijk; A-M C Dingemans; E F Smit; T J N Hiltermann; G den Hartog; M Jalving; T T Westphal; A Bhattacharya; F de Wilt; S M Ernst; A Boerma; L van Zijl; G F Rimmelzwaan; P Kvistborg; C A C M van Els; N Y Rots; D van Baarle; J B A G Haanen; E G E de Vries

doi:10.1016/j.esmoop.2023.100785

One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment

ESMO Open. 2023 Feb;8(1):100785. doi: 10.1016/j.esmoop.2023.100785. Epub 2023 Jan 10.

Authors

A A M van der Veldt¹, S F Oosting², R S N Fehrmann², C H GeurtsvanKessel³, R S van Binnendijk⁴, A-M C Dingemans⁵, E F Smit⁶, T J N Hiltermann⁷, G den Hartog⁴, M Jalving², T T Westphal⁸, A Bhattacharya², F de Wilt³, S M Ernst⁵, A Boerma⁹, L van Zijl¹⁰, G F Rimmelzwaan¹¹, P Kvistborg¹², C A C M van Els¹³, N Y Rots⁴, D van Baarle⁹, J B A G Haanen¹⁰, E G E de Vries²

Affiliations

¹ Department of Medical Oncology, Erasmus Medical Centre, Rotterdam, Netherlands; Radiology & Nuclear Medicine, Erasmus Medical Centre, Rotterdam, Netherlands. Electronic address: a.vanderveldt@erasmusmc.nl.
² Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
³ Department of Viroscience, Erasmus Medical Centre, Rotterdam, Netherlands.
⁴ Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
⁵ Department of Respiratory Medicine Erasmus Medical Centre, Rotterdam, Netherlands.
⁶ Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
⁷ Department of Pulmonary Diseases, University Medical Centre Groningen, Amsterdam, Netherlands.
⁸ Comprehensive Cancer Organization the Netherlands, Utrecht, Netherlands.
⁹ Department of Medical Microbiology and Infection Prevention, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
¹⁰ Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
¹¹ Research Centre for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.
¹² Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands.
¹³ Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands; Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Breakthrough Infections
COVID-19*
Humans
Neoplasms*
Patients